{"id":"W3095552675","doi":"10.1200/jco.20.01632","title":"Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; Agence Nationale de la Recherche; National Cancer Institute; Medical Research Council; National Institute for Health and Care Research; Agios Pharmaceuticals","keywords":"Medicine; Internal medicine; Neutropenia; Myeloid leukemia; Adverse effect; Gastroenterology; Azacitidine; Isocitrate dehydrogenase; Oncology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00307953,0.0002433631,0.001960782,0.000223284,0.00005586433,0.00002227558,0.0002959056,0.000560256,0.00007545526],"category_scores_gemma":[0.006493162,0.0001730169,0.0004841803,0.0004692752,0.0003016933,0.0002653875,0.0000755862,0.002027903,0.00002591382],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001170587,"about_ca_system_score_gemma":0.007469028,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000030706,"about_ca_topic_score_gemma":0.00008442987,"domain_scores_codex":[0.9953141,0.000462053,0.00272634,0.0003661534,0.0006332959,0.0004980936],"domain_scores_gemma":[0.9928179,0.003745188,0.00146841,0.000192765,0.0008321686,0.0009435169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2788719,0.009967294,0.1191502,0.0009635256,0.006257761,0.07955576,0.003473038,0.001518488,0.1493588,0.001544441,0.1022072,0.2471315],"study_design_scores_gemma":[0.3980317,0.2623661,0.09843273,0.001138483,0.003165611,0.00446978,0.002035141,0.04021345,0.0546578,0.00216745,0.1320638,0.001258012],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9468987,0.0001559954,0.00167874,0.04964367,0.000316317,0.000917574,0.00001759742,0.00002202655,0.0003493694],"genre_scores_gemma":[0.9772133,0.0007748895,0.0105873,0.009416717,0.001783696,0.00003780408,0.00002009494,0.00005473422,0.0001114592],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2523988,"threshold_uncertainty_score":0.9981577,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08517720452467968,"score_gpt":0.4167741424278661,"score_spread":0.3315969379031864,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}